Brief: Titan Pharma Received Confirmation From Nasdaq That Co Has Regained Compliance
22/07/2022 21:40
July 22 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMA - ON JULY 21, 2022, CO RECEIVED CONFIRMATION
FROM
NASDAQ THAT CO HAS REGAINED COMPLIANCE WITH $1.00 CLOSING BID
PRICE REQUIREMENT
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.